jcm-logo

Journal Browser

Journal Browser

Selected Papers from the 2nd International Electronic Conference on Clinical Medicine

A special issue of Journal of Clinical Medicine (ISSN 2077-0383).

Deadline for manuscript submissions: closed (5 July 2025) | Viewed by 893

Special Issue Editors


E-Mail Website
Guest Editor
Internal Medicine Department, University Hospital Strasbourg, 67000 Strasbourg, France
Interests: hematological diseases; vitamin B12-related diseases; telemedicine; heart failure prevention; telemonitoring
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Acute Care Medicine, University of Tokyo, Tokyo, Japan
Interests: emergency medicine; critical care medicine; intensive care medicine; fluorescence microscopy; cell biology; molecular biology; neuroscience; acute kidney injury and sepsis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The 2nd International Electronic Conference on Clinical Medicine (ECCM 2024) (https://sciforum.net/event/ECCM2024) is organized by the MDPI open access journal Journal of Clinical Medicine (Impact Factor 3.0) and will be held online from 13 to 15 November 2024. This conference aims to provide an online platform for leading scientists, where they can share their latest research findings and engage in exciting discussions. The main topics of the conference are as follows:

  • AI and Telemedicine;
  • Cardiology;
  • Clinical Psychology;
  • Dermatology;
  • Endocrinology and Metabolism;
  • Epidemiology and Public Health;
  • Gastroenterology and Hepatopancreatobiliary Medicine;
  • Hematology;
  • Infectious Diseases;
  • Nephrology and Urology;
  • Neurology and Stroke Neurology;
  • Nuclear Medicine and Radiology;
  • Obstetrics and Gynecology;
  • Oncology;
  • Ophthalmology;
  • Orthopedics;
  • Otolaryngology;
  • Pharmacology;
  • Psychiatry;
  • Pulmonology;
  • Stomatology.

The key time points of the conference are shown below:

- Abstract Submission: 16 August 2024
- Acceptance Notification: 9 September 2024
- Registration Deadline: 8 November 2024

This Special Issue is intended to collect the extended and expanded versions of the proceedings papers from the conference. All the conference participants will be granted a 20% discount on the Article Processing Charges (APCs).

Prof. Dr. Emmanuel Andrès
Prof. Dr. Kent Doi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiology
  • gastroenterology & hepatopancreatobiliary medicine
  • epidemiology & public health
  • AI & telemedicine
  • immunology
  • mental health
  • oncology & hematology
  • dermatology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

20 pages, 2701 KB  
Systematic Review
The Role of miRNAs as Predictors of Acute Lymphoblastic Leukemia Chemotherapy Toxicity in Children: A Systematic Review
by Małgorzata M. Mitura-Lesiuk, Maciej Dubaj, Karol Bigosiński and Mateusz Raniewicz
J. Clin. Med. 2025, 14(16), 5869; https://doi.org/10.3390/jcm14165869 - 20 Aug 2025
Viewed by 262
Abstract
Background/Objectives: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, accounting for 80% of leukemias in this group and about 25% of all cancers. The 5-year survival rate is now over 90%. Achieving such a good outcome is made possible by [...] Read more.
Background/Objectives: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, accounting for 80% of leukemias in this group and about 25% of all cancers. The 5-year survival rate is now over 90%. Achieving such a good outcome is made possible by the introduction of intensive, high-dose chemotherapy. However, it is associated with numerous complications, affecting up to 80% of patients. Among the most common of these are infections and intestinal, hepatic, hematological or neurological complications. For their effective treatment and prevention, it is necessary to develop predictors. High hopes in this aspect are placed on miRNAs. The aim of the following paper is to present the role of miRNAs as predictors of chemotherapy complications in children with ALL. Methods: A systematic review of the available literature in the PubMed, Scopus, Embase and Google Scholar scientific databases was conducted. Fourteen publications were included in the analysis. Results: Changes in miRNA expression and single-nucleotide polymorphisms in miRNAs are associated with complications of ALL therapy. Among the most notable are miR-1206 (in mucositis and myelotoxicity), miR-2053 (in neurotoxicity and mucositis), miR-938 and miR-3117 (in gastrointestinal toxicity and neurotoxicity), miR-1307 (in gastrointestinal toxicity and mucositis) and miR-323b (in gastrointestinal toxicity and myelotoxicity). In addition, miR-155, miR-3117 and miR-4268 may be potential therapeutic targets in complications of ALL therapy. Conclusions: miRNAs are good potential predictors of ALL chemotherapy toxicity and may be therapeutic targets in these complications. Full article
Show Figures

Figure 1

Back to TopTop